Consistent with previous findings, we found that the miR-30a-5p/CD73 axis is one of the mechanisms that regulate the development of tumor progression in pancreatic cancer, suggesting that interfering with miR-30a-5p/CD73 functions might be a therapeutic strategy for pancreatic cancer. This evidence concerns the gene NT5E and familial pancreatic carcinoma.